Thankfully, the outlook for those at highest risk of this deadly disease is improving thanks to new lung cancer screening techniques.
Three leading cancer experts from Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., discussed and answered your questions about lung cancer screening during a live, interactive online video chat on January 21, 2015.
The Lung Cancer Screening Program at Roswell Park is well established and has evolved to include the most innovative technologies proven to help catch lung cancers at their earliest, most curable stages. The multidisciplinary panel discussed the hope that lung cancer screening offers for those at high risk of the disease, such as long-term smokers.
What is the research behind lung cancer screening?
Who is eligible?
What tests are involved?
Nubeqa Delays Prostate Cancer Progression in Resistant Prostate Cancer
Nubeqa delays cancer progression and prolongs survival for men with a rising PSA but no evidence of metastases.
How much does it cost, and will my insurance cover it?
Samjot Dhillon is Chief of Pulmonary Medicine, Clinical Chief for Thoracic Medicine Clinics and Co-Chief of Endoscopy at Roswell Park Cancer Institute. Dr. Dhillon specializes in lung cancer screening and the diagnosis and staging of pulmonary malignancies.
Mary Reid is the Director of Collaborative Research in the Department of Medicine and a key facilitator in the Lung Cancer Screening Program at Roswell Park. Her research focuses on the early detection of lung cancer and the evaluation of genetic biomarkers in high-risk populations.
Pamela Germain is the Vice President of Managed Care and Outreach at Roswell Park. She educates health insurance companies on new, innovative cancer treatments to ensure patients receive coverage for the care they need and negotiates reimbursement for covered services.
Copyright © 2018 CancerConnect. All Rights Reserved.